[F1Offences in relation to pharmacovigilance obligations under the Implementing Regulation [F2and Schedule 12A] U.K.
210A.—(1) A holder is guilty of an offence if the holder—
(a)[F3in relation to a UKMA(NI), UKMA(UK), THR(NI) THR(UK) or Article 126a authorisation,] fails to comply with any requirement or obligation contained in a provision of the Implementing Regulation listed in paragraph (2); or
[F4(aa)in relation to a UKMA(GB) or THR(GB), fails to comply with any requirement or obligation contained in a provision of Schedule 12A listed in paragraph (2A); or]
(b)provides information which is false or misleading in a material particular to the licensing authority or the EMA pursuant to an obligation in the Implementing Regulation.
(2) The provisions mentioned in paragraph (1)(a) are—
(a)Chapter I (pharmacovigilance system master file);
(b)Sections 1 and 2 of Chapter II (minimum requirements for the quality systems for the performance of pharmacovigilance activities);
(c)Chapter III (minimum requirements for the monitoring of data in the Eudravigilance database);
(d)Chapter V (transmission of reports of suspected adverse reactions);
(e)Article 32 of Chapter VI (updates of risk management plans);
(f)Chapter VII (periodic safety update reports); and
(g)Chapter VIII (post-authorisation safety studies).
[F5(2A) The provisions of Schedule 12A mentioned in paragraph (1)(a) are—
(a)Part 1 (pharmacovigilance system master file);
(b)Parts 2 and 3 (minimum requirements for the quality systems in the performance of pharmacovigilance activities);
(c)Part 6 (transmission of reports of suspected adverse reactions);
(d)paragraph 24 (update of risk management plans);
(e)Part 8 (periodic safety update reports); and
(f)Part 9 (post-authorisation safety studies).]
(3) Subject to paragraph (4), a person guilty of an offence under this regulation is liable—
(a)on summary conviction to a fine not exceeding the statutory maximum; or
(b)on conviction on indictment to a fine.
(4) A person guilty of an offence under this regulation which relates to a breach of Article 34(5) or 36(3) of the Implementing Regulation [F6, or of paragraph 26(8) or 29(1) of Schedule 12A,] is liable—
(a)on summary conviction to a fine not exceeding the statutory maximum; or
(b)on conviction on indictment to a fine, to imprisonment for a term not exceeding two years or to both.]
Textual Amendments
F1Reg. 210A inserted (20.8.2013) by The Human Medicines (Amendment) Regulations 2013 (S.I. 2013/1855), regs. 1(1), 25
F2Words in reg. 210A heading inserted (31.12.2020) by S.I. 2019/775, reg. 175(2) (as amended by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 137(a))
F3Words in reg. 210A(1)(a) inserted (31.12.2020) by S.I. 2019/775, reg. 175(3)(a) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 137(b))
F4Reg. 210A(1)(aa) inserted (31.12.2020) by S.I. 2019/775, reg. 175(3)(b) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 137(b))
F5Reg. 210A(2A) inserted (31.12.2020) by S.I. 2019/775, reg. 175(4) (as amended by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 137(c))
F6Words in reg. 210A(4) inserted (31.12.2020) by S.I. 2019/775, reg. 175(5) (as inserted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 137(d))